Previous Article | Next Article ![]()
Journal of Bacteriology, January 2003, p. 525-533, Vol. 185, No. 2
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.2.525-533.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, University of Iowa School of Medicine,1 ITS Research Technologies, University of Iowa, Iowa City, Iowa 522422
Received 25 July 2002/ Accepted 24 September 2002
|
|
|---|
subunit of RNA polymerase leads to very low levels of hilA::Tn5lacZY expression, suggesting that HilD activates transcription of hilA by contacting and recruiting RNA polymerase to the hilA promoter. |
|
|---|
More than 25 genes needed to encode the invasion machinery are located on the 40-kb Salmonella pathogenicity island 1 (SPI-1) at centisome 63 on the chromosome of serovar Typhimurium (reviewed in reference 12). These genes encode transcriptional regulators, type III secretion system components, chaperones, and secreted effectors. Other secreted effector proteins (SigD/SopB, SopE, and SopE2) are encoded elsewhere on the chromosome of Salmonella (6, 21, 22, 24, 45, 49). Salmonella has evolved a highly complex regulatory scheme to control the expression of invasion genes. Environmental conditions such as growth phase, pH, oxygen tension, and osmolarity regulate expression of hilA, an OmpR/ToxR type transcriptional regulator that is a central node in the regulatory network (4, 5). HilA binds to the prg and inv promoters on SPI-1 to activate transcription of these operons (4, 5, 34). Expression of invF leads to induction of the sic/sip operon, sigD/sopB, and sopE (4, 5, 11, 13, 34, 47). A mutation in hilA results in reduced expression of genes within the prg, inv, and sic/sip operons, as well as drastically reduced invasion of cultured epithelial cells, invasion of M cells, and mouse virulence (4, 41).
Because of the crucial role HilA plays in invasion gene expression, much work has been done to study its regulation. Work from our laboratory has identified mutations in several genes, including hilE, pag, ams, and hha, that increase chromosomal hilA::Tn5lacZY expression, suggesting that they encode negative regulators of hilA (16, 17). Mutations in hilE and pag fall within previously undescribed genes that are Salmonella specific and do not contain typical DNA-binding or protein interaction motifs. RNase E is encoded by ams, and Hha is a small histone-like protein that is able to bind to the hilA promoter (17, 38). Lon protease has also recently been described as a negative regulator of hilA and invasion gene expression (46). Several groups have identified mutations in genes that result in decreased expression of hilA, indicating that csrAB, sirA/barA, pstS, fadD, envZ, fliZ, hilC/sirC/sprA, fis, and hilD have roles in hilA expression (1, 2, 27, 36, 42, 48). HilD, an AraC/XylS type transcriptional regulator, is a particularly important regulator of hilA expression, since a mutation in hilD results in a 14-fold decrease in chromosomal hilA::Tn5lacZY-080 expression and a 53-fold decrease in invasion of HEp-2 cells (42). It is believed that HilD directly regulates hilA expression since it has been shown to bind to hilA promoter sequences (40, 43). Currently, HilD is postulated to act as a derepressor of hilA expression, since HilD is needed to allow PhilA-lacZY expression from a plasmid reporter (42). However, when sequences upstream of the -39 position in the hilA promoter, termed the upstream repressing sequence (URS), were deleted from pLS31, the hilA reporter plasmid, HilD was no longer required for high-level hilA-lacZY expression (42). These data led to the proposal that HilD modulates hilA expression by counteracting the effect of a negative regulator(s) that may repress hilA by binding at the URS. According to this model, HilD would act as a derepressor and not as a typical activator of transcription, which is thought to be the common method of regulation by members of the AraC/XylS family (20, 37, 42).
In order to examine this model of HilD activity at the hilA promoter, we were interested in determining the effect of a hilD mutation in strains of Salmonella containing mutations in negative regulators of hilA. We reasoned that, if HilD is a derepressor of hilA expression, then deleting negative regulators of the hilA gene would increase hilA expression in the absence of HilD. Therefore, we created single, double, and triple mutations in the negative regulator elements hilE, hha, pag, and/or ams in a hilA-lacZY chromosomal reporter strain with or without functional HilD. Surprisingly, our results indicate that functional HilD is required for hilA expression even when known negative regulators are deleted. Additional experiments were performed that suggest further that HilD provides an essential activating function for hilA.
|
|
|---|
4.5 x 108 CFU/ml (28, 41). |
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
|
View this table: [in a new window] |
TABLE 2. Sequences of primers used in this work
|
hha,
hilE, and
URS mutations were created in the SL1344 chromosome or in pLS31 by using the procedure described by Datsenko and Wanner (14). Briefly, PCR primers were synthesized with 50 bp of homology to the 5' and 3' ends of the hilD gene, the hha gene, the hilE gene, and sequences from positions -314 to -68 in the hilA promoter. Each upstream primer also contains priming site 2 for pKD3 or pKD4, and each downstream primer contains priming site 1 for pKD3 or pKD4 (14). The primers are named hilD5FRT, hilD3FRT, hha5W, hha3W, hilE5W', hilE3W', -314hilA, and -68hilA. PCR amplification was performed with plasmid pKD3 as the template for the hha, hilE, and hilD primers and plasmid pKD4 as the template for the URS primers to yield the expected fragments of 1.1 kb for pKD3 and 1.6 kb for pKD4. The linear PCR fragments were purified and electroporated into SL1344 or into DH12S pLS31 carrying pKD46, and mutants were selected on L-chloramphenicol plates when pKD3 was used as the template plasmid or on L-kanamycin plates when pKD4 was used as the template plasmid. Several chloramphenicol-resistant, ampicillin-sensitive (Camr Amps) or kanamycin-resistant, ampicillin-sensitive (Kanr Amps) colonies were purified and found by PCR to have the transformed fragment recombined into the hilD gene, the hha gene, the hilE gene, or the sequence from positions -314 to -68 upstream of hilA. The Camr gene within the hha or hilE chromosomal sequence or the Kanr gene within the URS chromosomal sequence was excised by introduction of plasmid pCP20 (temperature-sensitive replicon, Ampr), which expresses the flp recombinase gene after thermal induction. Colonies that were Cams Amps or Kans Amps were shown to have excised the Camr or Kanr gene by PCR, and therefore these colonies carry a complete deletion of the hha gene, the hilE gene, or the sequence from -314 to -68 upstream of hilA. P22-mediated transduction. Antibiotic-resistant gene insertions were moved between strains by transduction with P22 HT int- as previously described (15). Transductants were selected on LB agar containing the appropriate antibiotics and 10 mM EGTA to prevent reinfection by P22.
ß-Galactosidase assays. ß-Galactosidase assays were performed with bacterial cultures by the method of Miller (39).
Introduction of rpoA mutations into SL1344.
Unmarked rpoA151, rpoA153, rpoA154, and rpoA155 point mutations were moved from LT2 into SL1344 by P22-mediated transduction of the zhb-1624::Tn10
marker that is 50% linked to rpoA mutations (Tn10
is a mini-Tet element that lacks the transposase sequences) (33). P22 lysates were made from several tetracycline-resistant (Tetr) SL1344 zhb-1624::Tn10
colonies and used to transduce Tetr into LT2 pepT7::MudJ. The pepT7::MudJ reporter in LT2 has a red colony phenotype on MacConkey agar; however, each rpoA mutation causes a decrease in pepT7::MudJ expression such that colonies appear white or light pink on MacConkey agar. Lysates from SL1344 that gave rise to LT2 pepT7::MudJ transductants that were white or light pink on MacConkey agar (
50%) were assumed to come from strains that harbored the rpoA mutation of interest. Subsequently, these SL1344 rpoA mutant strains were grown on Bochner media containing 24 µg of fusaric acid/ml to select for the loss of Tetr associated with zhb-1624::Tn10
(8). The pepT7::MudJ reporter or the hilA::Tn5lacZY reporter was then transduced into Tets SL1344 strains containing each rpoA mutation.
|
|
|---|
Figure 1A shows hilA::Tn5lacZY expression in strains containing mutations in negative regulators alone or in combination with the hilD::cam mutation. The wild-type strain expressed 421.5 Miller units of hilA::Tn5lacZY ß-galactosidase activity when grown in activating high-osmolarity, low-oxygen conditions. The presence of individual
hha,
hilE, ams::Tn5, or pag::Tn5 mutations in the strain increased hilA::Tn5lacZY expression 3.6-, 2.7-, 2.9-, or 6.0-fold, respectively. However, when the hilD::cam mutation was also present in the strains, individual mutations in negative regulators were unable to increase hilA::Tn5lacZY expression beyond the level seen in a hilD mutant alone. Therefore, mutations in hilE, hha, pag, or ams are unable to relieve repression of the hilA promoter in the absence of a functional hilD gene.
![]() View larger version (11K): [in a new window] |
FIG. 1. Single or multiple mutations in negative regulators do not relieve repression of hilA in the absence of hilD. (A) Effect of single mutations in hha, hilE, ams, and pag on the expression of a serovar Typhimurium hilA::Tn5lacZY reporter in the presence or absence of hilD. (B) Effect of multiple repressor mutations on hilA::Tn5lacZY chromosomal expression in the presence or absence of hilD. All bacterial cultures were incubated statically in LB with 1% NaCl under oxygen-limiting conditions to induce expression of the hilA::Tn5lacZY reporter. Data are representative of at least three independent experiments.
|
Because of the large increases in hilA::Tn5lacZY expression observed for double or triple negative regulator mutants, we expected that some combination of mutations would derepress the hilA promoter to the extent that HilD derepressing activity would be unnecessary. However, upon introduction of the hilD::cam mutation into each of these strains, we found that hilA::Tn5lacZY expression was always very low, similar to levels observed in a hilD mutant alone (Fig. 1B). Interestingly, we also observed that we could easily introduce the pag::Tn5 mutation into various strains when the hilD::cam mutation was already present. Double or triple negative regulator mutants that included the pag::Tn5 mutation expressed
40 Miller units of hilA::Tn5lacZY expression when HilD was absent (data not shown). These results seem inconsistent with the idea that HilD simply negates the function of negative regulators of hilA (i.e., derepression), since HilD is required to obtain wild-type levels of hilA expression even in the absence of several negative regulators. An alternative possibility is that the negative regulators modulate hilD expression, whereas another unidentified negative regulator is able to completely repress the hilA promoter in the absence of HilD, although this seems unlikely since many searches for negative regulators have been conducted. However, we examined this possibility by determining the effects of negative regulator mutations on PhilD-lacZY expression from plasmid pJB5 in Salmonella (Fig. 2). We found that mutations in hilE, hha, ams, or pag caused virtually no difference in hilD-lacZY expression, suggesting that these regulators do not function by altering the expression of hilD.
![]() View larger version (11K): [in a new window] |
FIG. 2. Effect of hha::Tn5, hilE::Tn5, ams::Tn5, or pag::Tn5 mutations on PhilD-lacZY expression from pJB5 in serovar Typhimurium. ß-Galactosidase activity for the hilD-lacZY reporter was quantitated as a percentage of the ß-galactosidase activity of the reporter in wild-type Salmonella, which was set at 100%. Bacterial cultures were incubated statically in LB with 1% NaCl under oxygen-limiting conditions. Data are representative of at least three independent experiments.
|
URS mutant did not reduce hilA::Tn5lacZY expression further.
![]() View larger version (11K): [in a new window] |
FIG. 3. Deletion of upstream promoter sequences results in an unactivatable hilA promoter. (A) Chromosomal or plasmid pLS31 sequences from positions -68 to -314 of the hilA promoter were replaced, by allelic exchange and deletion, with 84 bp of unrelated sequence to create a Salmonella hilA::Tn5lacZY reporter strain lacking URS sequences. (B) Expression of chromosomal hilA::Tn5lacZY was examined in the parent strain EE658 and the EE658 derivatives BJ2565 ( URS) and BJ2566 ( URS hilD::cam). (C) Effect of URS mutation created in plasmid pLS31 in Salmonella in the presence or absence of hilD. ß-Galactosidase expression was quantitated after growth in low-oxygen, high-osmolarity conditions. Data are representative of at least three independent experiments.
|
URS mutation, which leaves 84 bp of unrelated DNA in place of the URS from -68 to -314, could prevent the formation of an artificial promoter when created in pLS31, resulting in lower reporter expression. Therefore, we created the plasmid p
URS, with the
URS mutation (this mutation is identical to that constructed in the Salmonella chromosome) in pLS31, to examine its effect on PhilA-lacZY expression in Salmonella. We found that PhilA-lacZY expression was
5-fold lower from p
URS than from pLS31 and that expression from p
URS did not require the presence of HilD (Fig. 3B). This may indicate that the 84-bp insertion partially disrupts a cryptic artificial promoter or an artificial activation from the vector that has been brought closer to the hilA promoter. A less likely possibility is that low hilA expression from
URS PhilA-lacZY is due to some negative regulatory effect of the small fragment of DNA that has been left in place of upstream sequences in the hilA promoter.
The point mutation, L289F, in the
CTD of RNAP causes a severe decrease in hilA expression.
The data that we have presented here seem most consistent with the idea that HilD functions as an activator of hilA expression rather than as a derepressor. Many transcriptional activators, including various AraC/XylS regulators, are postulated to contact RNA polymerase at the
C-terminal domain (
CTD) to stabilize its interaction at promoter elements, facilitating closed complex formation and subsequent transcription (23, 37). Since HilD is a member of the AraC/XylS family of regulators, we thought it was possible that HilD contacts RNA polymerase at the
CTD to activate transcription of hilA. Point mutations in serovar Typhimurium LT2 chromosomal rpoA have been isolated that result in amino acid changes in the
CTD of RNA polymerase. These mutations cause a decrease in the expression of the pepT gene and are believed to disrupt interactions between the
CTD and the pepT activator, OxrA (33). We transduced the rpoA point mutations rpoA151, rpoA153, rpoA154, and rpoA155 by P22 transduction into the wild-type serovar Typhimurium strain SL1344 to determine their effects on the chromosomal hilA::Tn5lacZY reporter (Table 3). Control experiments confirmed that each mutation caused the expected decrease in the expression of pepT7::MudJ in strain SL1344, as had been previously reported for strain LT2 (33). Interestingly, three of the mutationsrpoA151, rpoA153, and rpoA154caused
2-fold increases in hilA expression that were dependent on the presence of HilD. However, the rpoA155 mutation, which changed leucine 289 to phenylalanine, caused a significant decrease in hilA expression, comparable to that observed in a strain containing a mutation in hilD alone.
|
View this table: [in a new window] |
TABLE 3. Effect of rpoA point mutations on hilA::Tn5lacZY expression
|
1.3-fold) in the SL1344 rpoA155 strain compared to its expression in SL1344 containing wild-type rpoA (1,236.5 ± 9.1 Miller units for SL1344 rpoA155 compared to 1,662.9 ± 17.7 Miller units for wild-type SL1344). In addition, we found that the effect of the rpoA155 mutation on hilA expression was not overcome by the expression of hilD from its own promoter or from the lac promoter on plasmids pJB1 and pJB3, respectively (Fig. 4). Plasmids pJB1 and pJB3 induce expression of PhilA-lacZY from pLS31 in Escherichia coli, similar to the high levels of hilA expression observed by Schechter et al. (42) in E. coli due to the expression of plasmid encoded hilD. E. coli (pLS31) containing parent plasmid pZC320 expresses 82.6 ± 4.3 Miller units of hilA-lacZY ß-galactosidase activity, whereas E. coli (pLS31) containing pJB1 or pJB3 expresses 573.4 ± 5.4 or 1,093.9 ± 48 Miller units of hilA-lacZY ß-galactosidase activity, respectively. A likely explanation for decreased hilA expression in the SL1344 rpoA155 strain is disruption of an interaction between HilD and the
CTD of RNA polymerase that is critical for activation of hilA transcription.
![]() View larger version (14K): [in a new window] |
FIG. 4. Expression of hilD from the lac promoter on plasmid pJB3 does not increase hilA::Tn5lacZY in SL1344 rpoA155. Plasmid pJB1 or pJB3 or the parent vector, pZC320, was introduced into SL1344 rpoA155 hilA::Tn5lacZY, and ß-galactosidase expression was quantitated from each strain after growth under low-oxygen, high-osmolarity conditions. Plasmid pJB1 expresses hilD from its own promoter, whereas plasmid pJB3 expresses hilD from the vector lac promoter. Data are representative of at least three independent experiments performed in triplicate.
|
|
|
|---|
The deletion of sequences upstream of -39 in a PhilA-lacZY plasmid reporter has been suggested to allow unregulated high-level expression of PhilA-lacZY in Salmonella and E. coli because sequences necessary for negative regulation of the promoter have been removed (42). However, our lab has noted that PhilA-lacZY expression from a hilA promoter deletion plasmid reporter can be variable, since its expression was much lower in E. coli strains HB101 and GS162 than in Salmonella or E. coli BW21355, the strain previously used by the Lee lab to demonstrate unregulated expression of the hilA promoter deletion plasmid (17). To further investigate the HilD derepressor model, we determined the effect of deleting URSs on hilA expression from the chromosome of Salmonella. The deletion of native hilA chromosomal promoter DNA from -68 to -314 did not result in high-level hilA::Tn5lacZY expression, as predicted by the model. Rather, very low expression of hilA was observed in the
URS strain, a level of expression that was similar to the low-level expression of hilA in a Salmonella strain containing a mutation in hilD. It is interesting that HilD binds in two regions of the hilA promoter, from positions -179 to -231 and from positions -49 to -101, that are almost completely removed in the
URS mutant strains (43). Therefore, HilD binding sequences appear to be important for chromosomal hilA expression.
It is unclear why plasmid hilA regulation does not reflect chromosomal hilA regulation when upstream promoter sequences are removed. One possibility is that upstream deletions in the plasmid hilA promoter place a cryptic -35 region present in the parent plasmid near a cryptic -10 sequence to create an active artificial promoter. Another possibility is that the promoter deletions bring an activator protein binding sequence within the parent plasmid into close proximity with the native hilA promoter so that interactions with RNA polymerase are stabilized to allow PhilA-lacZY expression. Although a number of possible explanations can be proposed to explain the plasmid results, we feel that it is important to recognize that experiments performed with chromosomal reporters are usually the most reliable and trusted for measuring gene expression.
Since HilD is required for wild-type levels of chromosomal hilA expression in the absence of several negative regulators and since HilD-binding sequences present in the URS appear to be important for hilA expression, we hypothesized that HilD is an activator of hilA transcription. In support of this idea, we found that a mutation in the
CTD of RNA polymerase that changes leucine 289 to phenylalanine results in reduced levels of hilA expression, a finding similar to that seen in a hilD::cam strain of Salmonella. The
CTD is thought to interact with many types of activators, including some of those within the AraC/XylS family, to allow transcription of various promoters (23, 37). In the
CTD, the first alpha helix and the loop between the third and fourth alpha helices are predicted to be DNA-binding determinants at promoter UP elements. However, leucine 289 is predicted to fall on the solvent-exposed face of the third alpha helix of the
CTD, such that it is unlikely to be involved in DNA binding and would be accessible for protein interactions (Fig. 5A and B) (18, 25). Residues in the third alpha helix, including leucine 289, have been shown to be important for activation of the P2 late promoter, and allele-specific suppressor mutations have been identified in the Ogr activator that overcome rpoA mutations to allow P2 late-promoter expression (3). Therefore, we propose that leucine 289 is important for a favorable interaction between the
CTD and HilD to occur, activating transcription of hilA (Fig. 5C and D). Recent unpublished data from our laboratory demonstrate that HilE is able to interact with HilD, suggesting that HilE repression of hilA may occur by inhibiting the ability of HilD to bind and recruit RNA polymerase to the hilA promoter.
![]() View larger version (50K): [in a new window] |
FIG. 5. Structural model of possible HilD interaction with the CTD on promoter DNA. (A) Ribbon structure of the CTD of RNA polymerase with leucine 289 highlighted and each alpha helix labeled as H1, H2, H3, or H4 (25). (B) Leucine 289 is predicted to be surface exposed on the CTD of RNA polymerase. (C) Structural model of the possible interaction of HilD and leucine 289 of the CTD of RNA polymerase, with DNA in the 5'-to-3' direction. (D) A different view of the model presented in panel C, showing the 3'-to-5' orientation of the DNA. Modeling was done by using Sybyl software (version 6.7; Tripos Associate, St. Louis, Mo.) on an O2 workstation (SGI, Mountain View, Calif.). Sybyl-Molcad was used to create panel B, which shows the solvent-exposed Connolly surface, by using the Connolly program to calculate the solvent-accessible surface of the molecule given the coordinates of its atoms (10). The Sybyl-Composer model was used to perform homology modeling for panels C and D to build structures for the CTD of HilD, from amino acids 211 to 309, based on the crystal structure of Rob, an AraC/XylS regulator that is homologous to HilD in its helix-turn-helix DNA-binding domain (31).
|
CTD is responsible for mediating an interaction with an activator other than HilD at the hilA promoter, but we find this idea unlikely for several reasons. First, our data suggest that HilD is critical for activation of hilA expression. In addition, HilD binds to the hilA promoter in an area from position -49 to -101, which would allow it to function as a typical class I transcriptional activator (23, 37). This makes HilD an excellent candidate for contacting the
CTD to recruit RNA polymerase to the hilA promoter. Several other positive regulatory elements of hilA expression have been identified. However, overexpression of HilD has been shown to overcome the effects of mutations in the positive regulators fis, fadD, fliZ, pstS, sirA, and envZ, suggesting that HilD is the positive regulator responsible for direct activation of the hilA promoter (35, 48). Interestingly, although overexpression of HilD is able to overcome the effects of mutations in other positive regulators of hilA, it does not overcome the effect of the L289F mutation in rpoA. These data suggest that the L289F mutation does not disrupt interaction with an activator of hilA expression whose loss can be compensated for by overexpression of HilD. Taken together, the data presented here indicate that HilD is an activator of hilA transcription and may function by contacting and recruiting the
CTD of RNA polymerase to the hilA promoter.
J.D.B. was supported by NIH predoctoral training grant 5T32 AI07511. This work was supported by NIH grant AI28268 to B.D.J.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»